HomeJSPR • NASDAQ
Jasper Therapeutics Inc
add
$2.80
1.41%
After Hours:(0.00%)0.00
$2.80
Closed: Aug 29, 8:00:00 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 27.08M | 69.30% |
Net income | -26.72M | -83.25% |
Net profit margin | — | — |
Earnings per share | -1.74 | -79.38% |
EBITDA | -26.82M | -70.88% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 39.51M | -63.01% |
Total assets | 46.47M | -59.21% |
Total liabilities | 22.97M | 68.62% |
Total equity | 23.50M | — |
Shares outstanding | 16.25M | — |
Price to book | 1.96 | — |
Return on assets | -130.09% | — |
Return on capital | -192.06% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -26.72M | -83.25% |
Cash from operations | -15.45M | -32.30% |
Cash from investing | 1.00K | 100.64% |
Cash from financing | 6.16M | 3,304.97% |
Net change in cash | -9.29M | 20.31% |
Free cash flow | -5.89M | 19.08% |
Previous close
$2.84
Day range
$2.78 - $2.86
Year range
$2.27 - $26.05
Market cap
46.47M USD
Avg Volume
252.42K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2019
Headquarters
Website
Employees
64
